| Dr Maxwell Scher, | |
|
830 Harrison Ave Ste 1400, Boston, MA 02118-2905 | |
| (617) 638-8124 | |
| Not Available |
| Full Name | Dr Maxwell Scher |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 830 Harrison Ave Ste 1400, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952987018 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 289676 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maxwell Scher, 830 Harrison Ave Ste 1400, Boston, MA 02118-2905 Ph: (617) 638-8124 | Dr Maxwell Scher, 830 Harrison Ave Ste 1400, Boston, MA 02118-2905 Ph: (617) 638-8124 |
News Archive
The American Cancer Society's 2013 Cancer Statistics report found that the incidence of melanoma continues to rise in both men and women. This is particularly concerning because skin cancer can often be easily prevented and detected.
New research suggests that men who eat more whole grain breakfast cereals reduce their risk of heart failure.
A set of proteins detected in urine by researchers at Boston Children's Hospital may prove to be the first biomarkers for Kawasaki disease, an uncommon but increasingly prevalent disease which causes inflammation of blood vessels that can lead to enlarged coronary arteries and even heart attacks in some children.
The Freezemobile freeze dryer from SP Scientific is designed to provide a convenient and flexible solution for high-quality preparation of peptides, proteins, plant materials and organic tissue.
Idera Pharmaceuticals, Inc. announced today preliminary data from a 4-week dose-ranging Phase 1 clinical trial of IMO-2125 in combination with ribavirin in 60 treatment-naïve patients with genotype 1 chronic hepatitis C virus (HCV) infection. In the trial, treatment with IMO-2125 in combination with ribavirin was well tolerated and achieved substantial decline in virus levels at two days after the first dose of IMO-2125 and after four weeks of treatment.
› Verified 7 days ago
Dr. Steven D. Rauch, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Elliott D. Kozin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-6545 | |
Katherine Nicole Vandenberg, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118 Phone: 617-638-8124 | |
Yoon Sun Chun, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Brigham And Women's Hospital Dept Of Plastic Surgery, Boston, MA 02115 Phone: 617-732-8181 Fax: 617-983-4534 | |
Jaimie Derosa, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 91 Newbury St, Suite 300, Boston, MA 02116 Phone: 617-262-8000 Fax: 617-262-8002 | |
Dr. Usama M Aboelkheir, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Smc8, Boston, MA 02135 Phone: 617-789-5004 Fax: 617-779-6481 | |
Phillip C Song, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3557 |